I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
DC120, a novel AKT inhibitor, preferentially suppresses nas..:
Qin, Juan
;
Ji, Jiao
;
Deng, Rong
...
Oncotarget. 6 (2015) 9 - p. 6944-6958 , 2015
Link:
https://doi.org/10.18632/oncotarget.3128
RT Journal T1
DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2
UL https://suche.suub.uni-bremen.de/peid=cr-10.18632_oncotarget.3128&Exemplar=1&LAN=DE A1 Qin, Juan A1 Ji, Jiao A1 Deng, Rong A1 Tang, Jun A1 Yang, Fen A1 Feng, Gong-Kan A1 Chen, Wen-Dan A1 Wu, Xiao-Qi A1 Qian, Xiao-Jun A1 Ding, Ke A1 Zhu, Xiao-Feng PB Impact Journals, LLC YR 2015 SN 1949-2553 JF Oncotarget VO 6 IS 9 SP 6944 OP 6958 LK http://dx.doi.org/https://doi.org/10.18632/oncotarget.3128 DO https://doi.org/10.18632/oncotarget.3128 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)